| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 418.467 | 486.927 | 431.265 | 362.740 | 364.245 | 391.786 | 339.827 | 348.184 | 341.539 | 318.790 |
| Total Income - EUR | 424.174 | 491.232 | 434.558 | 366.349 | 365.592 | 395.656 | 341.610 | 351.635 | 342.984 | 319.115 |
| Total Expenses - EUR | 387.614 | 406.270 | 365.410 | 314.609 | 318.155 | 353.225 | 279.889 | 293.515 | 309.463 | 267.301 |
| Gross Profit/Loss - EUR | 36.560 | 84.962 | 69.149 | 51.740 | 47.437 | 42.431 | 61.721 | 58.120 | 33.521 | 51.814 |
| Net Profit/Loss - EUR | 28.897 | 71.368 | 64.434 | 48.108 | 43.792 | 38.513 | 58.322 | 54.629 | 30.098 | 42.241 |
| Employees | 7 | 7 | 8 | 7 | 6 | 6 | 4 | 0 | 4 | 3 |
Check the financial reports for the company - Lotus Pharmedicals Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 66.957 | 62.468 | 60.451 | 56.181 | 52.151 | 48.277 | 44.619 | 42.156 | 39.457 | 37.676 |
| Current Assets | 393.765 | 428.980 | 416.867 | 393.254 | 385.376 | 379.157 | 398.254 | 409.693 | 376.713 | 407.662 |
| Inventories | 126.154 | 103.340 | 99.745 | 114.973 | 88.225 | 118.705 | 153.050 | 111.060 | 81.778 | 59.840 |
| Receivables | 230.070 | 228.162 | 222.477 | 204.876 | 173.925 | 202.613 | 187.926 | 218.084 | 155.926 | 175.767 |
| Cash | 37.541 | 97.478 | 94.645 | 73.405 | 123.225 | 57.839 | 57.278 | 80.549 | 139.009 | 172.055 |
| Shareholders Funds | 438.355 | 476.265 | 461.397 | 436.986 | 424.273 | 411.184 | 421.824 | 419.810 | 393.221 | 402.957 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 22.367 | 15.183 | 15.921 | 12.449 | 13.253 | 16.249 | 21.050 | 32.039 | 22.949 | 42.381 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4645 - 4645" | |||||||||
| CAEN Financial Year |
4645
|
|||||||||
Comments - Lotus Pharmedicals Srl